quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:31:17·57d
SECFiling
Innoviva Inc. logo

SEC Form 10-K filed by Innoviva Inc.

INVA· Innoviva Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • INVA
    Innoviva Inc.
    Health Care

Recent analyst ratings

  • Feb 17UpdateBTIG Research$35.00
  • Sep 30UpdateGoldman$17.00
  • Aug 11UpdateOppenheimer$45.00
  • Jul 14UpdateH.C. Wainwright$40.00
  • Jul 11UpdateCantor Fitzgerald$26.00
  • Mar 7UpdateScotiabank$55.00

Related

  • SEC27d
    Amendment: SEC Form 10-K/A filed by Innoviva Inc.
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Innoviva Inc.
  • SEC30d
    SEC Form DEF 14A filed by Innoviva Inc.
  • SEC57d
    Innoviva Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
  • INSIDER58d
    Chief Financial Officer Basso Stephen covered exercise/tax liability with 1,244 shares, decreasing direct ownership by 2% to 50,013 units (SEC Form 4)
  • INSIDER58d
    Chief Executive Officer Raifeld Pavel covered exercise/tax liability with 2,986 shares, decreasing direct ownership by 2% to 159,290 units (SEC Form 4)
  • INSIDER58d
    Chief Accounting Officer Zhen Marianne covered exercise/tax liability with 2,460 shares, decreasing direct ownership by 5% to 45,877 units (SEC Form 4)
  • PR63d
    Innoviva to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022